Literature DB >> 21734037

The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challenge.

Matthew R Reynolds1, Jonah B Sacha, Andrea M Weiler, Gretta J Borchardt, Chrystal E Glidden, Neil C Sheppard, Francesca A Norante, Philip A Castrovinci, Jacqueline J Harris, Henry T Robertson, Thomas C Friedrich, Adrian B McDermott, Nancy A Wilson, David B Allison, Wayne C Koff, Welkin E Johnson, David I Watkins.   

Abstract

It has recently been shown that polymorphism at the rhesus macaque TRIM5 locus can affect simian immunodeficiency virus (SIV) replication. Here we show that TRIM5 alleles can also affect acquisition of SIVsmE660. Animals coexpressing the TRIM5(TFP) and TRIM5(CypA) alleles took significantly longer to become infected with SIVsmE660, but not SIVmac239, after repeated limiting-dose intrarectal challenge than did animals expressing other TRIM5 allele combinations. Our results indicate that the TRIM5 alleles can be a barrier to productive infection and that this should be taken into account when designing acquisition studies using SIVsmE660 or related viruses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734037      PMCID: PMC3165772          DOI: 10.1128/JVI.05074-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses.

Authors:  Frank Kirchhoff
Journal:  Cell Host Microbe       Date:  2010-07-22       Impact factor: 21.023

2.  Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge.

Authors:  Matthew R Reynolds; Andrea M Weiler; Shari M Piaskowski; Holly L Kolar; Ann J Hessell; Madelyn Weiker; Kim L Weisgrau; Enrique J León; W Eric Rogers; Robert Makowsky; Adrian B McDermott; Rosanne Boyle; Nancy A Wilson; David B Allison; Dennis R Burton; Wayne C Koff; David I Watkins
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

3.  Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing.

Authors:  Benjamin N Bimber; Dawn M Dudley; Michael Lauck; Ericka A Becker; Emily N Chin; Simon M Lank; Haiying L Grunenwald; Nicholas C Caruccio; Mark Maffitt; Nancy A Wilson; Jason S Reed; James M Sosman; Leandro F Tarosso; Sabri Sanabani; Esper G Kallas; Austin L Hughes; David H O'Connor
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

4.  The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.

Authors:  Nanette Van Damme; Daniel Goff; Chris Katsura; Rebecca L Jorgenson; Richard Mitchell; Marc C Johnson; Edward B Stephens; John Guatelli
Journal:  Cell Host Microbe       Date:  2008-03-13       Impact factor: 21.023

Review 5.  Human cellular restriction factors that target HIV-1 replication.

Authors:  Klaus Strebel; Jeremy Luban; Kuan-Teh Jeang
Journal:  BMC Med       Date:  2009-09-16       Impact factor: 8.775

6.  TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species.

Authors:  Andrea Kirmaier; Fan Wu; Ruchi M Newman; Laura R Hall; Jennifer S Morgan; Shelby O'Connor; Preston A Marx; Mareike Meythaler; Simoy Goldstein; Alicia Buckler-White; Amitinder Kaur; Vanessa M Hirsch; Welkin E Johnson
Journal:  PLoS Biol       Date:  2010-08-24       Impact factor: 8.029

7.  Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.

Authors:  Nancy A Wilson; Brandon F Keele; Jason S Reed; Shari M Piaskowski; Caitlin E MacNair; Andrew J Bett; Xiaoping Liang; Fubao Wang; Elizabeth Thoryk; Gwendolyn J Heidecker; Michael P Citron; Lingyi Huang; Jing Lin; Salvatore Vitelli; Chanook D Ahn; Masahiko Kaizu; Nicholas J Maness; Matthew R Reynolds; Thomas C Friedrich; John T Loffredo; Eva G Rakasz; Stephen Erickson; David B Allison; Michael Piatak; Jeffrey D Lifson; John W Shiver; Danilo R Casimiro; George M Shaw; Beatrice H Hahn; David I Watkins
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

8.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

9.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

Authors:  Brandon F Keele; Hui Li; Gerald H Learn; Peter Hraber; Elena E Giorgi; Truman Grayson; Chuanxi Sun; Yalu Chen; Wendy W Yeh; Norman L Letvin; John R Mascola; Gary J Nabel; Barton F Haynes; Tanmoy Bhattacharya; Alan S Perelson; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

10.  TRIM5alpha Modulates Immunodeficiency Virus Control in Rhesus Monkeys.

Authors:  So-Yon Lim; Thomas Rogers; Tiffany Chan; James B Whitney; Jonghwa Kim; Joseph Sodroski; Norman L Letvin
Journal:  PLoS Pathog       Date:  2010-01-22       Impact factor: 6.823

View more
  49 in total

1.  Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody.

Authors:  John B Schell; Kapil Bahl; Nina F Rose; Linda Buonocore; Meredith Hunter; Preston A Marx; Celia C LaBranche; David C Montefiori; John K Rose
Journal:  Vaccine       Date:  2012-04-23       Impact factor: 3.641

2.  Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.

Authors:  Nicola Winstone; Aaron J Wilson; Gavin Morrow; Cesar Boggiano; Maria J Chiuchiolo; Mary Lopez; Marina Kemelman; Arielle A Ginsberg; Karl Mullen; John W Coleman; Chih-Da Wu; Sandeep Narpala; Ian Ouellette; Hansi J Dean; Feng Lin; Niranjan Y Sardesai; Holly Cassamasa; Dawn McBride; Barbara K Felber; George N Pavlakis; Alan Schultz; Michael G Hudgens; C Richter King; Timothy J Zamb; Christopher L Parks; Adrian B McDermott
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

3.  Generation of an HIV resistant T-cell line by targeted "stacking" of restriction factors.

Authors:  Richard A Voit; Moira A McMahon; Sara L Sawyer; Matthew H Porteus
Journal:  Mol Ther       Date:  2013-01-29       Impact factor: 11.454

4.  Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.

Authors:  Sudhir Pai Kasturi; Pamela A Kozlowski; Helder I Nakaya; Matheus C Burger; Pedro Russo; Mathew Pham; Yevgeniy Kovalenkov; Eduardo L V Silveira; Colin Havenar-Daughton; Samantha L Burton; Katie M Kilgore; Mathew J Johnson; Rafiq Nabi; Traci Legere; Zarpheen Jinnah Sher; Xuemin Chen; Rama R Amara; Eric Hunter; Steven E Bosinger; Paul Spearman; Shane Crotty; Francois Villinger; Cynthia A Derdeyn; Jens Wrammert; Bali Pulendran
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.

Authors:  Jonah B Sacha; In-Jeong Kim; Lianchun Chen; Jakir H Ullah; David A Goodwin; Heather A Simmons; Daniel I Schenkman; Frederike von Pelchrzim; Robert J Gifford; Francesca A Nimityongskul; Laura P Newman; Samantha Wildeboer; Patrick B Lappin; Daisy Hammond; Philip Castrovinci; Shari M Piaskowski; Jason S Reed; Kerry A Beheler; Tharsika Tharmanathan; Ningli Zhang; Sophie Muscat-King; Melanie Rieger; Carla Fernandes; Klaus Rumpel; Joseph P Gardner; Douglas H Gebhard; Juliann Janies; Ahmed Shoieb; Brian G Pierce; Dusko Trajkovic; Eva Rakasz; Sing Rong; Michael McCluskie; Clare Christy; James R Merson; R Brad Jones; Douglas F Nixon; Mario A Ostrowski; Peter T Loudon; Ingrid M Pruimboom-Brees; Neil C Sheppard
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

6.  Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.

Authors:  Timothy R Fouts; Kenneth Bagley; Ilia J Prado; Kathryn L Bobb; Jennifer A Schwartz; Rong Xu; Robert J Zagursky; Michael A Egan; John H Eldridge; Celia C LaBranche; David C Montefiori; Hélène Le Buanec; Daniel Zagury; Ranajit Pal; George N Pavlakis; Barbara K Felber; Genoveffa Franchini; Shari Gordon; Monica Vaccari; George K Lewis; Anthony L DeVico; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-13       Impact factor: 11.205

7.  Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.

Authors:  Caroline Petitdemange; Sudhir Pai Kasturi; Pamela A Kozlowski; Rafiq Nabi; Clare F Quarnstrom; Pradeep Babu Jagadeesh Reddy; Cynthia A Derdeyn; Lori M Spicer; Parin Patel; Traci Legere; Yevgeniy O Kovalenkov; Celia C Labranche; François Villinger; Mark Tomai; John Vasilakos; Barton Haynes; C Yong Kang; James S Gibbs; Jonathan W Yewdell; Dan Barouch; Jens Wrammert; David Montefiori; Eric Hunter; Rama R Amara; David Masopust; Bali Pulendran
Journal:  JCI Insight       Date:  2019-02-21

Review 8.  Animal models for HIV/AIDS research.

Authors:  Theodora Hatziioannou; David T Evans
Journal:  Nat Rev Microbiol       Date:  2012-12       Impact factor: 60.633

9.  DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge.

Authors:  Vainav Patel; Rashmi Jalah; Viraj Kulkarni; Antonio Valentin; Margherita Rosati; Candido Alicea; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Brandon F Keele; Julian W Bess; Michael Piatak; Jeffrey D Lifson; William T Williams; Xiaoying Shen; Georgia D Tomaras; Rama R Amara; Harriet L Robinson; Welkin Johnson; Kate E Broderick; Niranjan Y Sardesai; David J Venzon; Vanessa M Hirsch; Barbara K Felber; George N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-28       Impact factor: 11.205

10.  Strong TH1-biased CD4 T cell responses are associated with diminished SIV vaccine efficacy.

Authors:  Venkateswarlu Chamcha; Pradeep B J Reddy; Sunil Kannanganat; Courtney Wilkins; Sailaja Gangadhara; Vijayakumar Velu; Richard Green; G Lynn Law; Jean Chang; James R Bowen; Pamela A Kozlowski; Michelle Lifton; Sampa Santra; Traci Legere; Lynette S Chea; Lakshmi Chennareddi; Tianwei Yu; Mehul S Suthar; Guido Silvestri; Cynthia A Derdeyn; Michael Gale; Francois Villinger; Eric Hunter; Rama Rao Amara
Journal:  Sci Transl Med       Date:  2019-11-20       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.